PHK
BIIB icon

Point72 Hong Kong’s Biogen BIIB Stock Holding History

Point72 Hong Kong’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,000
Closed -$1.07M – 252
2022
Q3 		$1.07M Buy
4,000
+1,100
+38% +$234K 0.04% 537
2022
Q2 		$591K Sell
2,900
-2,000
-41% -$409K 0.02% 667
2022
Q1 		$1.03M Buy
4,900
+2,200
+81% +$478K 0.04% 499
2021
Q4 		$648K Sell
2,700
-7,700
-74% -$1.98M 0.02% 713
2021
Q3 		$2.94M Sell
10,400
-2,200
-17% -$721K 0.1% 288
2021
Q2 		$4.36M Buy
+12,600
New +$3.82M 0.14% 156

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Point72 Hong Kong's BIIB Position: Q3 2025 in Review

Point72 Hong Kong sold out of Biogen (BIIB) in Q3 2025, closing a stake of 11,083 shares — an estimated $1.39M sold.

Point72 Hong Kong first reported a position in BIIB in Q4 2014 and held it in 25 quarters. The position peaked at $6.33M in Q3 2021. 906 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Point72 Hong Kong reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 11,083 Biogen shares in Q3 2025, an estimated $1.39M.
  • Point72 Hong Kong first reported a position in Biogen in Q4 2014 and held it in 25 quarters.
  • Point72 Hong Kong's Biogen position peaked at $6.33M in Q3 2021.
  • 906 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.